Investigating Metabolic Disease with Human Pluripotent Stem Cells

The ability of human pluripotent stem cells (hPSCs) to differentiate into the many specialized cell types of the human body holds great promise for the study and treatment of human disease. Genome editing of hPSCs can allow for more accurate modeling of human diseases by introducing disease-specific mutations or correcting genetic aberrations in patient-derived induced pluripotent stem cell lines. Advances in genetic tools, such as clustered regularly interspaced short palindromic repeat (CRISPR) technology, have improved the ease and efficiency of genome editing in hPSCs.

View this webinar presentation by Dr. Chad Cowan, who discussed his research efforts to understand metabolic disease using the CRISPR/Cas system in human pluripotent stem cells to create genetic disease models.
Publish Date: May 13, 2016

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.